Activation of PPARβ/δ-AMPK pathway shown to slow liver fibrosis development

A study led by Manuel Vázquez Carrera, group leader at the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Centre (CIBERDEM) at the University of Barcelona, reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic dysfunction-associated steatotic liver disease).

With IPO money, Neumora eyes deals as CEO brings M&A chops from roles at AbbVie, JP Morgan

Neumora Therapeutics, a brain disease biotech born out of stitching together multiple neuroscience startups, is looking to replicate its original playbook by complementing its seven-drug

November 4, 2023

Mindfulness meditation curbs gaming addiction by altering brain responses

Mindfulness meditation significantly reduces gaming cravings and addiction severity in adults with Internet Gaming Disorder. The study reveals decreased activation in brain regions associated with

June 24, 2024

BIOS Health to launch precision medicine centre in US

Share this article BIOS Health will work with regional partners to set up the new research and clinical trials centre for neural digital therapies. Credit:

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.